Switch theme
Sign up to access all valuation multiples
Alicorp SA is a Peruvian company that manufactures, imports, exports and distributes mass consumption products across South America. Products are offered through four operating segments: mass Consumption, which contributes to the majority of firm revenue, B2B and aquaculture. Mass consumption products include various oils, hair care products, noodles, drinks, and food products. The B2B segment is the next contributor to revenue and manufactures and supplies products for industrial use such as laundry detergents, soap and stain removers, as well as beauty products. Aquaculture involves the provision of nutritional animal food and the Grinding segment. The company earns the majority of revenue domestically, with the rest coming from other South American countries.
1956
7.6K+
LTM Revenue $3.1B
LTM EBITDA $480M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Alicorp has a last 12-month revenue (LTM) of $3.1B and a last 12-month EBITDA of $480M.
In the most recent fiscal year, Alicorp achieved revenue of $3.0B and an EBITDA of $305M.
Alicorp expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Alicorp valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | XXX | $3.0B | XXX | XXX | XXX |
| Gross Profit | $3.1B | XXX | $802M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 27% | XXX | XXX | XXX |
| EBITDA | $480M | XXX | $305M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 10% | XXX | XXX | XXX |
| EBIT | $341M | XXX | $326M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $138M | XXX | $98.1M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $812M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Alicorp's stock price is PEN 9 (or $2).
Alicorp has current market cap of PEN 5.0B (or $1.4B), and EV of PEN 8.4B (or $2.3B).
See Alicorp trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.3B | $1.4B | XXX | XXX | XXX | XXX | $0.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Alicorp has market cap of $1.4B and EV of $2.3B.
Alicorp's trades at 0.8x EV/Revenue multiple, and 7.7x EV/EBITDA.
Equity research analysts estimate Alicorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alicorp has a P/E ratio of 10.1x.
See valuation multiples for Alicorp and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 4.9x | XXX | 7.7x | XXX | XXX | XXX |
| EV/EBIT | 6.9x | XXX | 7.2x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.1x | XXX | 14.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 4.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAlicorp's last 12 month revenue growth is 10%
Alicorp's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Alicorp's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alicorp's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Alicorp and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 43% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alicorp acquired XXX companies to date.
Last acquisition by Alicorp was XXXXXXXX, XXXXX XXXXX XXXXXX . Alicorp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Alicorp founded? | Alicorp was founded in 1956. |
| Where is Alicorp headquartered? | Alicorp is headquartered in Peru. |
| How many employees does Alicorp have? | As of today, Alicorp has 7.6K+ employees. |
| Is Alicorp publicy listed? | Yes, Alicorp is a public company listed on LIM. |
| What is the stock symbol of Alicorp? | Alicorp trades under ALICORC1 ticker. |
| When did Alicorp go public? | Alicorp went public in 1995. |
| Who are competitors of Alicorp? | Similar companies to Alicorp include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Alicorp? | Alicorp's current market cap is $1.4B |
| What is the current revenue of Alicorp? | Alicorp's last 12 months revenue is $3.1B. |
| What is the current revenue growth of Alicorp? | Alicorp revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Alicorp? | Current revenue multiple of Alicorp is 0.8x. |
| Is Alicorp profitable? | Yes, Alicorp is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Alicorp? | Alicorp's last 12 months EBITDA is $480M. |
| What is Alicorp's EBITDA margin? | Alicorp's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Alicorp? | Current EBITDA multiple of Alicorp is 4.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
